Literature DB >> 6300832

Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts.

J O'Donnell-Tormey, J P Quigley.   

Abstract

A chymostatin-sensitive step in the release of plasminogen activator from transformed fibroblasts has been described recently. By using synthetic peptidyl substrates, we have detected and characterized a chymostatin-sensitive peptidase activity in chicken embryo fibroblasts transformed by Rous sarcoma virus. The activity represents a neutral endopeptidase that exhibits phenylalanine specificity and is inhibited by diisopropyl fluorophosphate. A detailed inhibitor profile of the enzyme activity shows that it is distinct from other chymotrypsin-like phenylalanine-preferring peptidases. The endopeptidase activity in transformed fibroblasts is increased over that of parallel cultures of normal fibroblasts. The mechanism of enzyme inhibition by chymostatin is indicated by these studies, and the possible role of the enzyme in modulating plasminogen activator secretion is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300832      PMCID: PMC393373          DOI: 10.1073/pnas.80.2.344

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Cationic proteins from human neutrophil granulocytes. Evidence for their chymotrypsin-like properties.

Authors:  R Rindler-Ludwig; H Braunsteiner
Journal:  Biochim Biophys Acta       Date:  1975-02-27

2.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Human cathepsin G. Catalytic and immunological properties.

Authors:  P M Starkey; A J Barrett
Journal:  Biochem J       Date:  1976-05-01       Impact factor: 3.857

4.  Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs.

Authors:  R F Diegelmann; B Peterkofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

5.  New hypothesis of insulin secretion.

Authors:  P E Lacy; S L Howell; D A Young; C J Fink
Journal:  Nature       Date:  1968-09-14       Impact factor: 49.962

6.  Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones.

Authors:  J C Powers; B F Gupton; A D Harley; N Nishino; R J Whitley
Journal:  Biochim Biophys Acta       Date:  1977-11-23

7.  Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate.

Authors:  R H Goldfarb; J P Quigley
Journal:  Biochemistry       Date:  1980-11-25       Impact factor: 3.162

Review 8.  Shedding from the cell surface of normal and cancer cells.

Authors:  P H Black
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

9.  A zinc metalloendopeptidase associated with dog pancreatic membranes.

Authors:  R A Mumford; A W Strauss; J C Powers; P A Pierzchala; N Nishino; M Zimmerman
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

10.  Sbustrate specificity of the elastase and the chymotrypsin-like enzyme of the human granulocyte.

Authors:  M Zimmerman; B M Ashe
Journal:  Biochim Biophys Acta       Date:  1977-01-11
View more
  2 in total

1.  Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.

Authors:  J Yavelow; M Collins; Y Birk; W Troll; A R Kennedy
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants.

Authors:  S Fairbairn; R Gilbert; G Ojakian; R Schwimmer; J P Quigley
Journal:  J Cell Biol       Date:  1985-11       Impact factor: 10.539

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.